Irland - Englisch - HPRA (Health Products Regulatory Authority)

aristo pharma gmbh - solifenacin succinate - film-coated tablet - solifenacin

Irland - Englisch - HPRA (Health Products Regulatory Authority)

accord healthcare limited - solifenacin succinate - film coated tablet - 5 milligram - solifenacin

Irland - Englisch - HPRA (Health Products Regulatory Authority)

accord healthcare limited - solifenacin succinate - film coated tablet - 10 milligram - solifenacin

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - solifenacin succinate, quantity: 5 mg - tablet, film coated - excipient ingredients: maize starch; lactose monohydrate; purified water; hypromellose; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; macrogol 400 - solifenacin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - solifenacin succinate, quantity: 10 mg - tablet, film coated - excipient ingredients: hypromellose; lactose monohydrate; purified water; maize starch; magnesium stearate; titanium dioxide; macrogol 8000; purified talc; iron oxide red - solifenacin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - solifenacin succinate, quantity: 5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; purified water; maize starch; hypromellose; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; macrogol 400 - solifenacin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - solifenacin succinate, quantity: 10 mg - tablet, film coated - excipient ingredients: hypromellose; lactose monohydrate; purified water; maize starch; magnesium stearate; titanium dioxide; macrogol 8000; purified talc; iron oxide red - solifenacin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Malta - Englisch - Medicines Authority

teva pharma b.v. (utrecht) swensweg 5, 2031 ga haarlem, netherlands - solifenacin succinate - film-coated tablet - solifenacin succinate 5 mg - urologicals

Malta - Englisch - Medicines Authority

teva pharma b.v. (utrecht) swensweg 5, 2031 ga haarlem, netherlands - solifenacin succinate - film-coated tablet - solifenacin succinate 10 mg - urologicals

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

viatris limited - solifenacin succinate 10mg;   - film coated tablet - 10 mg - active: solifenacin succinate 10mg   excipient: hypromellose   iron oxide red iron oxide yellow lactose magnesium stearate maize starch propylene glycol purified talc titanium dioxide - solifenacin viatris is indicated for the treatment of unstable bladder with symptoms of increased urinary urgency, frequent microurination, and/or urge incontinence.